NANOCRYSTAL TECHNOLOGY: INCREASING ORAL BIOAVAILABILITY OF LOW-SOLUBLE DRUGS
Nanocrystal technology enables the production of solid drug particles with a particle size below 1000 nm without the need ORG BUTTERSCOTCH CHOC for any copyright system.By reducing the size of the particles of drugs with low solubility in water, increasing the surface area and decreasing the thickness of the diffusion layer leads to an increase in